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Abstract
Background
West Nile virus (WNV) is a Flaviviridae most often transmitted by mosquitos. Clinical manifestations vary from
no symptoms to neuroinvasive disease. Mortality is rare, but patients with neuroinvasive disease have a fatality
rate of 4-14%. Diagnosis is made on epidemiological, clinical and serological criteria. Treatment is based on
symptomatic and support therapy. WNV neuroinvasive disease seems associated to advancing age and
diabetes, but poor prognosis risk factors are still not clearly recognized.
During 2017-2018 10 patients affected by WNV infection were admitted to our Hospital (Policlinico of Modena):
3 patients had a rapid fatal outcome and 3 needed intensive care transfer. We report the most representative
case.
Case Report
A 81-yr-old man from Emilia-Romagna was admitted to our unit with a 6 days history of fever (>38℃), fatigue,
nausea, vomiting, hiccough and mild cognitive impairment treated with amoxicillin. Past medical history: type 2
diabetes mellitus, arterial hypertension, permanent pacemaker for type 3 atrioventricular block. Referred
exposure to farm animals. No recent travels abroad. Chest x-ray showed a retrocardiac opacity, so empiric
levofloxacin was started for suspected community acquired pneumonia. After two days the patient began
lethargic with a Glasgow Come Score < 8. Neuroinvasive WNV disease was confirmed by
electroencephalogram and rachicentesis. Before serologic results acyclovir and dexamethasone were initiated
without benefit and patient diedon the fifth day after admission. 
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Conclusions
Risk factors for poor prognosis related to WNV Infection are still not clearly identified. Our patient underwent
unexpected rapid clinical deterioration before invasive treatment could positively affect prognosis. This
underlines the importance of clinical alert to WNV infections during transmission season in endemic areas and
the necessity of more data on fatal WNV cases to define criteria to promptly recognize high-risk patients. 
Keywords
encephalitis; meningoencephalitis; neuroinvasive disease; West Nile virus; fatal meningoencephalitis.
Introduction
West Nile virus (WNV) is a mosquito-borne single positive-stranded RNA virus of the family Flaviviridae. Different
mosquito species can acquire and transmit WNV1, Culex genus is the most involved2. Transmission
ofWNV infection was also reported through blood transfusion, organ transplantation, sexual contact and
vertically, through the placenta3,4,5,6,7. The predominant reservoir are birds8. The resulting illness varies from no
symptoms or influenza-like symptoms to neuroinvasive disease. In particular neuroinvasive disease occurs in
less than 1% of the infections with a fatality rate of about 10%2,9,10. From epidemiological data we know that
advancing age and diabetes are associated with the risk of developingWNV neuroinvasive disease9,11. Probably
other chronic conditions (e.g. chronic heart failure) can predispose to neuroinvasive disease11,12. In contrast risk
factors for poor prognosis are still not clearly recognized. No therapy is currently approved for use in humans.
Since the beginning of the 2017 transmission season, Italy has been one of the most affected Country in the EU
Members States and neighboring countries (first in in 2018 with 576 reported cases13), and Emilia-Romagna one
of the region with the higher incidence. Both lineage 1 and 2 are present in Italy. The disease incidence has
increased since 200811,14, and during the two year period 2017-2018 an increase has been registered in Europe.
Data collected by our Institution (Policlinico of Modena) have confirmed the European trend2,15: of 10 patients
affected by West Nile Virus infection, 8 of them were admitted in 2018. Most of the patients affected (7 of 10)
 were primarly admitted in Infectivology, 2 were referred to our unit (Internal Medicine and Critical Care) and 1
to Hematology. 3 cases had a rapid fatal outcome, including the 2 patients admitted in 2017. About 1/3 (3 of
10) of cases needed transfer in intensive care, and 2 of them survived.
We report the most representative case.
Case Report
A 81-yr-old man from Emilia-Romagna region was admitted to our unit with fever (>38℃, 100.4℉) since last 6
days, fatigue, nausea, vomiting, hiccough and mild cognitive impairment referred by his family. His medical
history was significant for: type 2 diabetes mellitus, arterial hypertension, permanent pacemaker since
September 2016 for type 3 atrioventricular block. His current history was notable for exposure to farm animals.
He had not travelled abroad in the previous months.
At admission examination, the patient was aware and spatial and temporal oriented. The remaining physical
examination was normal. His vital signs were: blood pressure 150/70 mmHg, heart rate 88/min, oxygen
saturation 97%, respiratory rate 24/min, temperature 38℃ (100.4℉). The laboratory findings showed:
hemoglobin 12.5 g/dL, hematocrit 34.4%, leukocytes 7 × 103/mm3, PLT 171× 103/mm3, C-reactive protein 0.6
mg/dL, glucose 293 mg/dL and sodium 130 mEq/L. Kidney and liver function tests were normal. Chest X-ray
showed a bad-defined retro cardiac opacityin the left lung. The abdominal ultrasound was negative. Since the
patient took amoxicillin for 5 days before admission, empiric levofloxacin was initiated for suspected community
acquired pneumonia. Two sets of blood cultures and urine culture were collected without growth of any
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microorganism. Pneumococcal and Legionella urinary antigen tests were negative. The patient persisted febrile
despite antipyretic therapy (Figure 1).
Figure 1. Patient’s temperature chart. Auricular temperature was taken four times a day (6 a.m., 12 a.m., 18
p.m., 12 p.m.)
On the third day of admission the patient began lethargic with a Glasgow come score < 8.A head CT scan
showed a slightly enlarged ventricular system without evidence of ischemic or hemorrhagic stroke, space-
occupying lesions or asymmetry (Figure 2).
Figure 2. Head CT scan of the patient. There is a mild dilatation of the ventricular system without others
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abnormalities 
 
An electroencephalogram (EEG) was performed with the evidence of diffuse slower theta EEG background
without focal anomalies. Thus, EEG was indicative of diffuse brain injury. It was impossible to perform magnetic
resonance imaging because of the pacemaker contraindication. Analysis of cerebrospinal fluid (CSF)
demonstrated 14 cells/µL (norm: < 4 cells/ µL) with a predominance of lymphocytes and monocytes, 229 mg/dL
protein (norm:12–60 mg/dL), 118 mg/dL glucose (norm: 40–80 mg/dL) and 3.1 mmol/L lactate (norm: 0.5-2.4
mmol/L). CSF culture was negative for bacteria, fungi and mycobacteria. Real-time polymerase chain reaction
analysis of CSF did not detect any virus, bacteria or yeast. On the advice of Infectivologist we started therapy
with acyclovir 750mg t.i.d. and dexamethasone 3g q.i.d.. The patient diedthe next day, on the fifth day after
admission. Finally liquor serology showed the presence of  immunoglobulin (Ig)M and IgG against West Nile
Virus. 
Conclusions
As underlined above, risk factors for poor prognosis are still not clearly identified to date.
A variety of factors might contribute to fatal outcome (e.g. immunosuppression states, diabetes, age) but more
comprehensive epidemiologic and clinical summaries are needed. Our patient had an advanced age and
suffered from diabetes mellitus and arterial hypertension. He underwent unexpected rapid clinical deterioration
before any invasive treatment could be carried out. Thus, data on larger numbers of fatal WNV cases may help
to promptly recognize high-risk patients who could benefit from early invasive management.
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